{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:26:04Z","timestamp":1740633964345,"version":"3.38.0"},"reference-count":0,"publisher":"Clinical and Experimental Rheumatology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.55563\/clinexprheumatol\/dyjcsn","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:05:07Z","timestamp":1740585907000},"source":"Crossref","is-referenced-by-count":0,"title":["Challenges in international investigator-led rare disease clinical trials and the case for optimism in inclusion body myositis"],"prefix":"10.55563","author":[{"given":"Merrilee","family":"Needham","sequence":"first","affiliation":[{"name":"Department of Neurology, Fiona Stanley Hospital, Western Australia;  Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Western Australia;  School of Medicine, Notre Dame University, Western Australia; and Perron Institute for Neurological and Translational Science, Western Australia, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh A.","family":"Badrising","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Leiden, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Beer","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Western Australia; and Perron Institute for Neurological and Translational Science, Western Australia, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Heim","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center, Kansas City, KS, USA. aheim2@kumc.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Althea","family":"Doverty","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine & Innovative Therapeutics, Murdoch University, Western Australia; and Perron Institute for Neurological and Translational Science, Western Australia, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annik","family":"Panicker","sequence":"additional","affiliation":[{"name":"Perron Institute for Neurological and Translational Science, Western Australia, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center, Kansas City, KS, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"34330","published-online":{"date-parts":[[2025,2,26]]},"container-title":["Clinical and Experimental Rheumatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:05:08Z","timestamp":1740585908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.clinexprheumatol.org\/abstract.asp?a=21866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":0,"alternative-id":["CER18317"],"URL":"https:\/\/doi.org\/10.55563\/clinexprheumatol\/dyjcsn","relation":{},"ISSN":["1593-098X"],"issn-type":[{"value":"1593-098X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}